Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Stopped CDC's decision to down-select vaccine development to single candidate, ACAM2000

Conditions

• Smallpox

Interventions

• BIOLOGICAL: ACAM1000
• BIOLOGICAL: vaccinia virus (calf lymph) smallpox vaccine: Dryvax

Sponsor

Sanofi Pasteur, a Sanofi Company